Cargando…
Benefit finding in long-term prostate cancer survivors
PURPOSE: Benefit finding (BF) represents possible positive changes that people may experience after cancer diagnosis and treatment and has proven to be valuable to the psychological outcome. Knowledge of such beneficial consequences of prostate cancer (PCa) is limited in long-term survivors (> 5...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236447/ https://www.ncbi.nlm.nih.gov/pubmed/33447865 http://dx.doi.org/10.1007/s00520-020-05971-3 |
_version_ | 1783714540336185344 |
---|---|
author | Lassmann, Irène Dinkel, Andreas Marten-Mittag, Birgitt Jahnen, Matthias Schulwitz, Helga Gschwend, Jürgen E. Herkommer, Kathleen |
author_facet | Lassmann, Irène Dinkel, Andreas Marten-Mittag, Birgitt Jahnen, Matthias Schulwitz, Helga Gschwend, Jürgen E. Herkommer, Kathleen |
author_sort | Lassmann, Irène |
collection | PubMed |
description | PURPOSE: Benefit finding (BF) represents possible positive changes that people may experience after cancer diagnosis and treatment and has proven to be valuable to the psychological outcome. Knowledge of such beneficial consequences of prostate cancer (PCa) is limited in long-term survivors (> 5 years). Thus, the present study investigated the occurrence of benefit finding (BF) and its determinants in a large sample of (very-) long-term PCa survivors. METHODS: BF was assessed in 4252 PCa survivors from the German database “Familial Prostate Cancer” using the German version of the Benefit Finding Scale (BFS). Associations between BF and sociodemographic, clinical, and psychosocial (e.g., depressive and anxiety symptoms and perceived severity of the disease experience) variables were analyzed using hierarchical multiple linear regression analysis. RESULTS: Mean age at survey was 77.4 years (SD = 6.2) after a mean follow-up of 14.8 years (SD = 3.8). Mean BFS score was 3.14 (SD = 1.0); the prevalence of moderate-to-high BF (score ≥ 3) was 59.7%. Younger age at diagnosis, lower educational level, and higher perceived severity of the disease experience were predictive of BF. Objective disease severity or family history of PCa was not uniquely associated with BF. CONCLUSIONS: BF occurs in older, (very-) long-term PCa survivors. Our findings suggest that the self-asserted severity of the disease experience in a patient’s biography is linked to BF in the survivorship course above all tangible sociodemographic and clinical factors. IMPLICATIONS FOR CANCER SURVIVORS: PCa survivors may express BF regardless of clinical disease severity. Treating urologists should consider inquiring BF to enrich a patient’s cancer narrative. |
format | Online Article Text |
id | pubmed-8236447 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-82364472021-07-09 Benefit finding in long-term prostate cancer survivors Lassmann, Irène Dinkel, Andreas Marten-Mittag, Birgitt Jahnen, Matthias Schulwitz, Helga Gschwend, Jürgen E. Herkommer, Kathleen Support Care Cancer Original Article PURPOSE: Benefit finding (BF) represents possible positive changes that people may experience after cancer diagnosis and treatment and has proven to be valuable to the psychological outcome. Knowledge of such beneficial consequences of prostate cancer (PCa) is limited in long-term survivors (> 5 years). Thus, the present study investigated the occurrence of benefit finding (BF) and its determinants in a large sample of (very-) long-term PCa survivors. METHODS: BF was assessed in 4252 PCa survivors from the German database “Familial Prostate Cancer” using the German version of the Benefit Finding Scale (BFS). Associations between BF and sociodemographic, clinical, and psychosocial (e.g., depressive and anxiety symptoms and perceived severity of the disease experience) variables were analyzed using hierarchical multiple linear regression analysis. RESULTS: Mean age at survey was 77.4 years (SD = 6.2) after a mean follow-up of 14.8 years (SD = 3.8). Mean BFS score was 3.14 (SD = 1.0); the prevalence of moderate-to-high BF (score ≥ 3) was 59.7%. Younger age at diagnosis, lower educational level, and higher perceived severity of the disease experience were predictive of BF. Objective disease severity or family history of PCa was not uniquely associated with BF. CONCLUSIONS: BF occurs in older, (very-) long-term PCa survivors. Our findings suggest that the self-asserted severity of the disease experience in a patient’s biography is linked to BF in the survivorship course above all tangible sociodemographic and clinical factors. IMPLICATIONS FOR CANCER SURVIVORS: PCa survivors may express BF regardless of clinical disease severity. Treating urologists should consider inquiring BF to enrich a patient’s cancer narrative. Springer Berlin Heidelberg 2021-01-15 2021 /pmc/articles/PMC8236447/ /pubmed/33447865 http://dx.doi.org/10.1007/s00520-020-05971-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Lassmann, Irène Dinkel, Andreas Marten-Mittag, Birgitt Jahnen, Matthias Schulwitz, Helga Gschwend, Jürgen E. Herkommer, Kathleen Benefit finding in long-term prostate cancer survivors |
title | Benefit finding in long-term prostate cancer survivors |
title_full | Benefit finding in long-term prostate cancer survivors |
title_fullStr | Benefit finding in long-term prostate cancer survivors |
title_full_unstemmed | Benefit finding in long-term prostate cancer survivors |
title_short | Benefit finding in long-term prostate cancer survivors |
title_sort | benefit finding in long-term prostate cancer survivors |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236447/ https://www.ncbi.nlm.nih.gov/pubmed/33447865 http://dx.doi.org/10.1007/s00520-020-05971-3 |
work_keys_str_mv | AT lassmannirene benefitfindinginlongtermprostatecancersurvivors AT dinkelandreas benefitfindinginlongtermprostatecancersurvivors AT martenmittagbirgitt benefitfindinginlongtermprostatecancersurvivors AT jahnenmatthias benefitfindinginlongtermprostatecancersurvivors AT schulwitzhelga benefitfindinginlongtermprostatecancersurvivors AT gschwendjurgene benefitfindinginlongtermprostatecancersurvivors AT herkommerkathleen benefitfindinginlongtermprostatecancersurvivors |